SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4126this from iv thread. hadn't seen that before but great if true.. "...ubob zagorin-6/17/2007
4125xml.10kwizard.combob zagorin-6/15/2007
4124RNA Really New Advances Jun 14th 2007 From The Economist print edition Moleculabob zagorin-6/15/2007
4123Isis at needham right now.. wsw.combob zagorin-6/13/2007
4122Rosetta Genomics In-Licenses Proprietary MicroRNAs for Therapeutic use From Rockbob zagorin-6/13/2007
4121zacks new coverage as of 6/6/07 $15 Target on Isis Pharmaceuticals Posted Thubob zagorin-6/7/2007
4120301012 presentation... ir.isispharm.combob zagorin-6/5/2007
4119here's a longer response from dogdazed on the IV board that i think you willbob zagorin-6/4/2007
4118PSA is pretty well correlated with disease state, but survival and tumor responstuck-6/4/2007
4117i'm no expert but don't the following results in advanced metastatic patbob zagorin-6/4/2007
4116The lung cancer results definitely look better, though it's an open label, utuck-6/4/2007
4115and another post fron IV that puts the results in a pretty good light.. "bob zagorin-6/4/2007
4114a very cool digital presentation from ogx website on how antisense works and spebob zagorin-6/3/2007
4113Study Presented at ASCO Shows Encouraging One-Year and Overall Survival Results bob zagorin-6/3/2007
4112there's another study reported on sunday in nsclc.. meanwhile, some good disbob zagorin-6/3/2007
4111This seems barely worth pursuing. There are additional AEs from adding OGX-11 atuck-6/2/2007
4110ASCO results prnewswire.com >>Study Presented at ASCO Shows Encouraging bob zagorin-6/2/2007
4109interesting though, as tiger has gotten pretty rave reviews. this from IV site: bob zagorin-6/1/2007
4108>>Applied Biosystems/ U.S. Department of Defense Contract for Prototype Intuck-6/1/2007
4107OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO Thursday May 31bob zagorin-5/31/2007
4106New device detects avian flu strains fast Tue May 29, 2007 8:14 PM ET By Maggiebob zagorin-5/29/2007
4105oncogenix at asco... isispharm.combob zagorin-5/28/2007
4104this is from IV... "...301012 Phase 3 - annual meeting In the Q and A at bob zagorin-5/25/2007
4103Strange Ph III. Open lable, uncontrolled, restricted to 40 participants from Ian@SI-5/25/2007
4102isispharm.combob zagorin-5/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News